Annual report pursuant to Section 13 and 15(d)

Note 5 - Stock Incentive Plan (Details Textual)

v3.24.1
Note 5 - Stock Incentive Plan (Details Textual) - USD ($)
12 Months Ended
Mar. 31, 2022
Apr. 30, 2020
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2017
Apr. 30, 2016
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     508,902 604,064 [1]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value     $ 131,413      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)     $ 4.01      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Exercise Price (in dollars per share)     4.27      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)     $ 3.37      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount     $ 2.8      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)     2 years 6 months      
General and Administrative Expense [Member]            
Share-Based Payment Arrangement, Expense     $ 1,014,046 $ 818,164    
Research and Development Expense [Member]            
Share-Based Payment Arrangement, Expense     $ 883,803 $ 823,099    
Restricted Stock Units (RSUs) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     368,345 403,522    
Options Held [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     508,902      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) 5,100,000 3,100,000     1,600,000 700,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) 2,000,000 1,500,000        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     0      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)     10 years      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     368,345      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Minimum [Member] | Share-Based Payment Arrangement, Option [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     1 year      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Maximum [Member] | Share-Based Payment Arrangement, Option [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     4 years      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Vesting Monthly Over One Year [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     10,000      
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)     $ 2.37      
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)     $ 3.16      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Vesting 6/48ths on Six-months and 1/48th After [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     443,182      
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Vesting Quarterly Over One Year [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     55,720      
[1] 604,064 options vest as follows: options to purchase 533,552 shares of the Company’s common stock vest 6/48ths on the six-month anniversary of vesting commencement date and 1/48th per month thereafter; options to purchase 60,512 shares of the Company’s common stock vest quarterly over one year; and options to purchase 10,000 shares of the Company’s common stock vest monthly over one year. Exercise prices range from $1.59 to $3.95 per share.